Camp4 Therapeutics Corp
CAMPNasdaqCIK 1736730HealthcareFiscal year ends Dec 31
Reports and events: 49 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2816:47 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-063740 |
| 2026-08-3117:06 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001753037-26-000007 |
| 2026-08-1919:03 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-357272 |
| 2026-08-1316:23 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-056760 |
| 2026-08-1316:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-056758 |
| 2026-08-0517:43 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001753037-26-000003 |
| 2026-08-0407:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-052150 |
| 2026-07-2707:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-049661 |
| 2026-06-1216:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-042846 |
| 2026-05-1409:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001736730-26-000033 |
| 2026-05-0716:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-032146 |
| 2026-05-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-032096 |
| 2026-04-2307:01 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001736730-26-000026 |
| 2026-03-2407:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001736730-26-000021 |
| 2026-03-1117:57 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001953107-26-000005 |
| 2026-03-0516:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001736730-26-000016 |
| 2026-03-0516:06 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001736730-26-000015 |
| 2026-01-0916:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001736730-26-000004 |
| 2025-12-2317:58 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001953107-25-000021 |
| 2025-12-2316:59 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001736730-25-000116 |
| 2025-12-1817:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-058009 |
| 2025-12-1807:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001736730-25-000111 |
| 2025-11-0616:19 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001736730-25-000094 |
| 2025-11-0616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001736730-25-000092 |
| 2025-10-0108:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001736730-25-000074 |
| 2025-09-1519:08 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001953107-25-000007 |
| 2025-09-1117:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-201410 |
| 2025-09-1116:25 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-024279 |
| 2025-09-1007:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001736730-25-000072 |
| 2025-08-1416:19 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001736730-25-000070 |
| 2025-08-1416:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001736730-25-000068 |
| 2025-06-1316:03 ET | 8-K | 5.07 Shareholder vote results | 0001736730-25-000043 |
| 2025-05-1606:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001736730-25-000041 |
| 2025-05-1316:26 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001736730-25-000039 |
| 2025-05-1316:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001736730-25-000037 |
| 2025-04-3007:00 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0001736730-25-000027 |
| 2025-03-2716:14 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001736730-25-000022 |
| 2025-03-2716:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001736730-25-000021 |
| 2025-03-1808:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001736730-25-000004 |
| 2025-01-0716:16 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-001679 |
| 2024-11-2116:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001410578-24-002045 |
| 2024-11-2116:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-121533 |
| 2024-10-2217:50 ET | SC 13D | Ownership report, active investor | 0001193125-24-241180 |
| 2024-10-2216:17 ET | SC 13D | Ownership report, active investor | 0001104659-24-110570 |
| 2024-10-2216:16 ET | SC 13D | Ownership report, active investor | 0001104659-24-110566 |
| 2024-10-1516:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-108583 |
| 2024-10-0706:03 ET | S-1/A | Registration statement, amended | 0001104659-24-106393 |
| 2024-09-2616:10 ET | S-1/A | Registration statement, amended | 0001104659-24-103141 |
| 2024-09-2013:35 ET | S-1 | Registration statement | 0001104659-24-101618 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.